CC-90009

CRBN-based GSPT1 molecular glue degrader

intravenous agent in Ph. I for AML + MDS

from phenotypic screen of CRBN mod library

J. Med. Chem., Feb. 16, 2021

Celgene/Bristol Myers Squibb, San Diego, CA

1. The Bristol Myers Squibb (BMS)/Celgene GSPT1 degrader (CC-90009) is a CRBN-based molecular glue (CELMoD). It is a clinical candidate in Ph. I for AML and MDS, and in…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks